Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel
NCT01807780 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 262
Last updated 2017-05-05
Summary
The purpose of this study is to determine if multiple vaccination in military personnel may be correlated with the appearance of poorly defined diseases as symptomatic multisyndrome, autoimmune or lymphoproliferative disorders. At the same time, considering possible interference between different vaccines, proteins and polysaccharides, living and inactivated, the study aims to assess the immunogenicity and efficacy also in relation to the specific Human Leucocyte Antigens (HLA) genetic structure.
Conditions
- Vaccination Adverse Events
- Vaccination Failure
- Specific Antibody Response
Interventions
- BIOLOGICAL
-
biological monitoring
Sponsors & Collaborators
-
University of Roma La Sapienza
lead OTHER
Principal Investigators
-
Raffaele D'Amelio, MD · sapienza università di roma
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2014-12-31
- Completion
- 2015-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Markers of Favorable Response to FcRn Inhibitors(INFORM)
NCT06685055 ·Status: RECRUITING
-
Markers of Favorable Response to Complement Inhibitors Therapy
NCT06455709 ·Status: RECRUITING
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3
-
Vaccine Coverage and Primary Sjögren'Syndrome
NCT04224454 ·Status: COMPLETED
-
The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
NCT00215800 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
NCT03052751 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
NCT00533091 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers
NCT06637865 ·Status: RECRUITING ·Phase: PHASE1
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING
-
Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease
NCT05728684 ·Status: UNKNOWN ·Phase: NA
-
Immune Profiles in Myasthenia Gravis
NCT05095103 ·Status: UNKNOWN
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT04951622 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome
NCT06898372 ·Status: COMPLETED
-
Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
NCT05132569 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
NCT01461018 ·Status: COMPLETED ·Phase: PHASE3
-
Transverse Myelitis Related to SARS-CoV-2 Vaccines
NCT05178264 ·Status: COMPLETED
-
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)
NCT05439044 ·Status: COMPLETED
-
Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
NCT03018535 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
NCT00997412 ·Status: UNKNOWN ·Phase: NA
-
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
NCT05379634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024 ·Status: RECRUITING ·Phase: NA
-
An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
NCT03896295 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
NCT00168025 ·Status: COMPLETED ·Phase: PHASE3